In a retrospective cohort study of patients with PAD and DM under either SGLT-2 inhibitors, GLP-1 receptor agonists or sulfonylureas, GLP-1 receptor agonist prescription was associated with a significantly lower rate of lower limb amputation [326]. Here, GLP1R is linked to peripheral arterial disease.